Genomic data encompasses information related to the structure, function, and variation within an organism's genome. It forms the foundation of precision medicine, from identifying disease-causing variants to stratifying patients for genetically targeted therapies. But as the volume of this data grows, so do the challenges of storing, analyzing, and making it accessible across research programs.
Recently, our team had the pleasure of attending the 16th Annual Patient Recruitment and Retention Summit, a hallmark event in the field of clinical research and patient advocacy. Hosted in an intimate, knowledge-sharing environment, this summit brought together experts from across the globe to share insights, strategies, and innovations aimed at enhancing patient involvement in clinical research. We were proud to sponsor a booth, which served as a hub for discussions, networking, and sharing our contributions to the field. In this blog, we’ll share the themes that rose to the top in our discussions.
In observance of Rare Disease Day, our latest episode of the Genetics Podcast presents a fascinating conversation with John Matthews, who was recently promoted to Chief Medical Officer at ReCode Therapeutics. This special episode not only commemorates the day dedicated to raising awareness for rare diseases but also showcases the innovative strides being made in the field of genetic medicine for the diagnosis and treatment of rare diseases.
In our latest whitepaper, "Beyond the bench: The role of patient empowerment in shaping precision medicine research," we examine how patient involvement is transforming the field of genomics- and biomarker-driven research. In highlighting the shift towards patient-centric models, we emphasise the importance of including patient insights in the development of new treatments.
In today's digital age, scientists and medical professionals are harnessing the power of healthcare data to unravel the genetic foundations of various diseases. But despite the growing portfolio of precision medicines, their integration into healthcare systems is not without its hurdles. This blog explores the challenges and opportunities of integrating precision medicine into healthcare systems.
Precision medicine is an approach to treatment and prevention that accounts for individual differences in genes, environment, and lifestyle. It represents a shift away from one-size-fits-all care toward decisions shaped by a patient's specific biology. Yet achieving health equity, in which every individual has the chance to attain their highest level of health regardless of background, remains a fundamental and unmet goal. Despite the promise of precision medicine, healthcare systems globally face significant challenges in providing equal access to these advances across all communities.
Parkinson's disease affects an estimated one to two percent of the population over the age of sixty, though the true prevalence is likely higher. As the research landscape evolves, the most consequential advances are those that connect basic science to actionable clinical strategy, particularly in genetics, biomarkers, and patient identification.
We recently had the privilege of hosting a booth and speaking in the Precision Medicine World Conference (PMWC) 2024, an event that stands at the intersection of technology, medicine, and research. This gathering of the minds is where the future of healthcare is debated, shaped, and set into motion. Our team returned invigorated by the discussions, collaborations, and insights that PMWC fostered, reflecting a shared ambition to redefine the boundaries of personalised medicine. In this recap, we share three pivotal insights that resonated with us and will continue to shape our vision for the future of precision medicine.
In clinical genetics, digital health technology now plays a central role in how genetic data is generated, interpreted, and acted upon. Digital health broadly refers to the use of information and communications technologies in medicine and other health professions to manage illnesses, health risks, and wellness. In genetics specifically, this spans chatbots assisting with patient admissions, machine learning algorithms enhancing genomic analysis and reporting, and platforms that coordinate testing, counseling, and data workflows. The result is not just operational efficiency. It is a structural shift toward broader access, more consistent service delivery, and more tailored care in a field where the volume and complexity of data continue to grow.
In the rapidly advancing realm of precision medicine, healthcare professionals (HCPs) are witnessing a transformative shift in their roles. This approach, which tailors treatment to the individual's genetic makeup, lifestyle, and environment, demands a new set of skills and knowledge from HCPs – including physicians, nurses, and pharmacists. They are now at the forefront of integrating complex genetic information into patient care, navigating ethical dilemmas, and maintaining an up-to-date understanding of technological innovations. This blog post explores how precision medicine is reshaping the responsibilities and expertise of HCPs, and what this means for patient care.